TAS2R16 Antibody

What is TAS2R16 and what are its key structural features?

TAS2R16 (Taste receptor type 2 member 16) is a G-protein coupled receptor in the T2R protein family. In humans, the canonical protein consists of 291 amino acid residues with a molecular mass of approximately 34 kDa. It is primarily localized in the cell membrane and undergoes post-translational modifications, including glycosylation. TAS2R16 is expressed in a subset of gustducin-positive taste receptor cells of the tongue and functions as a gustducin-coupled receptor involved in the perception of bitter compounds in both the oral cavity and gastrointestinal tract .

What are the common detection methods for TAS2R16 expression in tissues?

TAS2R16 can be detected using several immunological techniques, with Western Blot being the most common application. Other frequently employed methods include ELISA and immunofluorescence (IF) . For tissue-specific localization, immunocytochemistry (ICC) is also commonly used. Researchers typically employ anti-TAS2R16 antibodies that recognize specific epitopes, such as the C-terminal region, for reliable detection across these platforms .

How does TAS2R16 signaling work at the molecular level?

TAS2R16 functions through G protein-coupled signaling pathways. Upon binding of bitter compounds (particularly β-glycosides like salicin), TAS2R16 activates the G protein gustducin, which triggers intracellular calcium release. This can be experimentally measured as increases in intracellular Ca²⁺ levels after ligand binding. The receptor's sensitivity is often quantified using EC₅₀ values, which represent the concentration of bitter ligands that induces a response halfway between baseline and maximum . This signaling cascade is critical for both sensory perception and non-taste physiological functions of TAS2R16.

What is the optimal methodology for measuring TAS2R16 serum levels?

For measuring TAS2R16 serum protein levels, enzyme-linked immunosorbent assay (ELISA) is the method of choice. A standardized protocol involves:

• Collection of peripheral venous blood with subsequent incubation at room temperature for 30 minutes

• Centrifugation to extract serum from the pellet

• Storage of serum in 2 mL containers at -80°C until analysis

• Using a validated TAS2R16 ELISA kit (sensitivity typically <0.1 ng/mL with detection range of 0.312-20 ng/mL)

• Following manufacturer's instructions for sandwich ELISA procedure

• Measuring optical density at 450 nm using a microplate photometer

• Running samples in duplicate to ensure reliability

This approach has been successfully employed in clinical studies examining TAS2R16 levels in conditions such as pituitary adenoma .

How can researchers effectively perform TAS2R16 genotyping?

TAS2R16 genotyping can be efficiently conducted using real-time PCR with specific genotyping assays. The methodology includes:

• Using appropriate TaqMan® genotyping assays for target SNVs (such as rs860170, rs978739, and rs1357949)

• Employing a real-time PCR quantification system (e.g., "StepOnePlus")

• Analyzing individual genotypes using Allelic Discrimination program during real-time PCR

• Conducting random retesting on approximately 5% of DNA samples to validate results

• Assessing genotype call rate (ideally >99.5%) and agreement rate between duplicate samples (>99.8%)

This approach provides high precision and reliability for TAS2R16 genetic variant identification in research studies.

What controls should be included when validating a new anti-TAS2R16 antibody?

When validating a new anti-TAS2R16 antibody, researchers should include several controls:

• Positive controls: Tissues or cell lines known to express TAS2R16 (e.g., gustducin-positive taste receptor cells)

• Negative controls: Samples lacking TAS2R16 expression or knockdown/knockout models

• Specificity controls: Preincubation with blocking peptides derived from the immunogen sequence

• Cross-reactivity assessment: Testing against related taste receptors

• Expression validation: Comparison with TAS2R16 mRNA expression using RT-PCR

• Molecular weight confirmation: Verifying that the observed molecular weight matches the expected size (around 34 kDa theoretical, though observed at ~72 kDa in some studies)

• Multiple application testing: Validation across several methods (WB, ICC, IF, ELISA) to ensure consistent performance

How can mutations in TAS2R16 be analyzed for their impact on receptor function?

To analyze the functional impact of TAS2R16 mutations, researchers employ several methodological approaches:

• Construction of mutagenized receptors:

  • Using PCR mutagenesis to introduce specific mutations

  • Subcloning into an expression vector with appropriate tags for detection

  • Confirming sequences using standard sequencing methods

• Cell surface expression analysis:

  • Transfecting HEK-293T cells with wild-type and mutant TAS2R16 plasmids

  • Co-transfecting with Gα16gust44 chimera (containing gustducin elements)

  • Fixing cells with paraformaldehyde and staining with antibodies

  • Measuring surface expression via flow cytometry

  • Normalizing data to wild-type TAS2R16 values

• Functional response measurements:

  • Measuring ligand-induced calcium mobilization using fluorescent calcium indicators

  • Constructing dose-response curves to determine EC₅₀ values

  • Comparing receptor sensitivity and efficacy between wild-type and mutant forms

These methods have revealed that certain mutations, such as the K172 variant (corresponding to the G-allele at nucleotide position 516), can significantly decrease receptor sensitivity to bitter compounds like salicin .

How do TAS2R16 receptor variants affect bitter compound sensitivity across species?

Analysis of TAS2R16 variants across species reveals differential sensitivities to bitter compounds, particularly β-glycosides. To investigate these differences, researchers:

• Amplify TAS2R16 genes from genomic DNA of different species

• Express these variants in cellular systems (typically HEK cells)

• Measure receptor responses to bitter compounds using calcium mobilization assays

• Compare EC₅₀ values to quantify relative sensitivities

Studies have demonstrated that human TAS2R16 shows the highest sensitivity to salicin among primates, while macaque TAS2R16 exhibits a markedly reduced response. These functional differences can be mapped to specific amino acid residues that determine ligand specificity and sensitivity. For instance, the W261 position has been identified as crucial for receptor interactions with certain β-glycosides .

What methodologies enable mapping of small molecule binding sites on TAS2R16?

Mapping small molecule binding sites on complex membrane proteins like TAS2R16 presents significant challenges, especially without protein co-crystal structures. Advanced methodologies include:

• Shotgun Mutagenesis platform:

  • Systematically mutating individual amino acids in the receptor

  • Expressing each mutant in a cellular system

  • Testing functional responses to small molecule ligands

  • Identifying critical residues for ligand binding

• Chimeric receptor analysis:

  • Creating chimeric receptors by ligating fragments from different species' TAS2R16

  • Identifying regions responsible for species-specific responses

  • Narrowing down to specific amino acid residues through further targeted mutagenesis

• Functional validation:

  • Measuring calcium mobilization in response to ligand binding

  • Comparing EC₅₀ shifts between wild-type and mutant receptors

  • Constructing models of receptor-ligand interactions based on identified critical residues

These approaches have successfully mapped binding sites for multiple small molecules on TAS2R16, even for low-affinity interactions that are challenging for traditional analytical techniques .

How can TAS2R16 genetic variations be analyzed in relation to disease susceptibility?

Analysis of TAS2R16 genetic variations in disease contexts involves multiple methodological approaches:

• Case-control genetic association studies:

  • Genotyping TAS2R16 SNVs (e.g., rs860170, rs978739, rs1357949) in patient and control populations

  • Analyzing genotype and allele frequency distributions

  • Performing binomial logistic regression analysis to calculate odds ratios

  • Applying appropriate statistical corrections for multiple testing (e.g., Bonferroni correction)

• Protein level correlation:

  • Measuring serum TAS2R16 levels using validated ELISA methods

  • Correlating protein levels with specific genotypes

  • Analyzing associations between protein levels and disease phenotypes

• Functional studies:

  • Investigating how disease-associated variants affect receptor function

  • Examining impacts on inflammatory pathways (e.g., NF-kB pathway)

  • Assessing effects on cellular processes relevant to disease pathogenesis

These approaches have been applied to investigate TAS2R16 variants in conditions like pituitary adenoma, revealing associations between specific variants and disease characteristics, as well as elevated TAS2R16 serum levels in disease states .

What is the role of TAS2R16 in inflammatory processes and how can it be studied?

TAS2R16 plays a significant role in modulating inflammatory responses. Research methodologies to investigate this include:

• Inflammatory pathway analysis:

  • Examining how TAS2R16 activation affects NF-kB pathway signaling

  • Measuring proinflammatory cytokine release in response to receptor activation

  • Assessing TAS2R16's influence on immune cell function (macrophages, dendritic cells)

• Disease model studies:

  • Investigating TAS2R16 expression and function in inflammatory disease contexts

  • Correlating receptor variants with inflammatory biomarkers

  • Exploring potential anti-inflammatory properties through receptor modulation

• Mechanistic investigations:

  • Studying how TAS2R16 affects the tumor microenvironment

  • Examining receptor influence on angiogenesis, tumor growth, and immune suppression

  • Investigating interactions with chronic inflammation processes

Research has shown that TAS2R16 activation can inhibit inflammatory responses, including suppression of proinflammatory cytokine release, suggesting potential therapeutic applications in conditions involving inflammation .

How can researchers analyze TAS2R16's potential role in tumor development?

To investigate TAS2R16's potential involvement in tumor development, researchers can employ several methodological approaches:

Evidence suggests that TAS2R16 may influence tumor development through multiple mechanisms, including effects on cell proliferation, apoptosis, immune responses, and inflammation within the tumor microenvironment. Studies have begun exploring associations between TAS2R16 variants and various cancers, including colon cancer and pituitary adenoma .

What are the critical parameters for optimizing Western blot analysis using anti-TAS2R16 antibodies?

For optimal Western blot performance with anti-TAS2R16 antibodies, researchers should consider:

• Antibody selection: Choose antibodies validated specifically for Western blot, targeting well-conserved epitopes (e.g., C-terminal region antibodies like ARP66295_P050)

• Sample preparation:

  • Include appropriate protease inhibitors to prevent degradation

  • Verify protein concentration using reliable quantification methods

  • Consider membrane fraction enrichment techniques for increased sensitivity

• Electrophoresis conditions:

  • Use appropriate percentage gels (typically 10-12%) for the expected molecular weight

  • Note that observed molecular weight may differ from calculated (observed ~72kDa vs. calculated ~34kDa)

• Transfer and blocking:

  • Optimize transfer conditions for membrane proteins

  • Use 4-5% BSA in TBS-T for blocking rather than milk (which can contain bioactive compounds)

• Antibody dilution:

  • Start with recommended dilutions (typically 1:500 - 1:2000)

  • Optimize based on signal-to-noise ratio

• Controls:

  • Include positive control (tissue/cells known to express TAS2R16)

  • Consider blocking peptide controls to confirm specificity

  • Include loading controls appropriate for membrane proteins

Careful optimization of these parameters ensures reliable and reproducible detection of TAS2R16 protein in Western blot applications.

How can researchers effectively design experiments to study TAS2R16 receptor trafficking and localization?

To study TAS2R16 trafficking and localization effectively, researchers can employ these methodological approaches:

• Immunofluorescence microscopy:

  • Use anti-TAS2R16 antibodies (dilution 1:200-1:1000) validated for IF applications

  • Co-stain with markers for cellular compartments (ER, Golgi, plasma membrane)

  • Employ confocal microscopy for precise subcellular localization

• Surface expression quantification:

  • Transfect cells with tagged TAS2R16 constructs

  • Measure cell surface expression using non-permeabilized antibody staining

  • Quantify by flow cytometry as described in functional mutation studies

• Live cell imaging:

  • Create fluorescent protein fusions with TAS2R16

  • Monitor receptor trafficking in real-time

  • Assess responses to ligands or cellular stressors

• Biotinylation assays:

  • Selectively label surface proteins with biotin

  • Isolate with streptavidin pulldown

  • Detect TAS2R16 by Western blot to quantify surface expression

• Subcellular fractionation:

  • Separate cellular compartments through differential centrifugation

  • Analyze TAS2R16 distribution across fractions

  • Verify fractionation quality with compartment-specific markers

These approaches enable comprehensive analysis of how TAS2R16 traffics to the cell surface and responds to various experimental conditions, providing insights into receptor regulation and function.